Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Blurring of vision; Period pains; Near fainting; Nausea; Fainting; This is a spontaneous report from a contactable consumer received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106040750499600-Y7XHU and Safety Report Unique Identifier GB-MHRA-ADR 25418332. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jun2021 as single dose for COVID-19 immunisation. Medical history included pregnancy. She was no longer pregnant at the time of reporting. She has not had symptoms associated with COVID-19, not had a COVID-19 test, and not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced nausea and fainting on an unspecified date; period pains and near fainting on 04Jun2021. Case narrative: Period started and was accompanied by extreme nausea, pains and fainting/temporary blurring of vision on an unspecified date. This lasted for around 40 minutes and was very different to normal period reactions. She has not tested positive for COVID-19 since having the vaccine. The patient recovered from nausea and fainting on an unspecified date; recovering from period pains and near fainting; while outcome of blurring of vision was unknown. Case was reported as medically significant by health authority. No follow-up attempts are needed, information about batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166